iRobo

Target SDGs

Target Users (Target Impact Group)

Small and Medium-sized Enterprises

Distributors / Implementing Organizations

Product is still in the prototyping phase.

Manufacturing/Building Method

The product is manufactured in India.

Intellectural Property Type

Trademark

User Provision Model

The product is still in its early phases and not commercially available. However it will be distributed through distributor channels and strategic partners. ^{Interview with designer, July 2020}

Distributions to Date Status

50 products have been distributed as of July 2020 (Interview with designer, July 2020)

Design Specifications

The iRobo is a fully autonomous system with several components. The key characteristics of the product are: it is non-invasive, it generates a computerized screening report, it's autonomous features removes operator variability and the need for a skilled operator, a remote diagnosis can be provided, no pupil dilation required, and it offers real time audio guidance.

Product Schematics

Technical Support

Provided by the manufacturer.

Replacement Components

Unknown

Lifecycle

Unknown

Manufacturer Specified Performance Parameters

Manufacturer specified performance targets include: quick, user comfort, accuracy of readings, and high image quality.

Vetted Performance Status

Safety standard test IEC-60601-1. A pilot study with 450+ participants at Aditya Jyot Eye Hospital Mumbai has been completed and clinical trials are in progress.

Safety

Unknown

Complementary Technical Systems

Unknown

Academic Research and References

Compliance with regulations

IEC and ISO standards were considered in the design. IEC safety tests will be performed to ensure product safety.

Evaluation methods

Safety testing, clinical trials

Other Information

Won 1st Prize in UpStart Indian Business Model Competition by IIT Kanpur. Recognized as one of India’s “Top 16 Ideas of 2019” by Falling Walls Lab India.